Page last updated: 2024-08-23

paclitaxel and Sarcoma, Epithelioid

paclitaxel has been researched along with Sarcoma, Epithelioid in 64 studies

Research

Studies (64)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's25 (39.06)18.2507
2000's21 (32.81)29.6817
2010's13 (20.31)24.3611
2020's5 (7.81)2.80

Authors

AuthorsStudies
Fairchild, C; Johnston, K; Kadow, JF; Lee, FL; Long, BH; Rose, WC; Vyas, DM; Wittman, MD1
Choi, Y; Jin, Y; Jung, HY; Kaur, N; Kim, DK; Kim, EK; Kim, ES; Lee, K; Min, KH; Min, YK; Park, MK; Xia, Y1
Agar, N; Blessing, WA; Colby, AH; Colson, YL; Digesu, CS; Grinstaff, MW; Hachey, KJ; Korunes-Miller, JT; Kumar, A; Liu, R; Mahvi, DA; Raut, CP; Regan, MS; Shih, A; Tal-Mason, A1
Bay, JO; El-Ghazzi, N1
Berry, S; Bordeianu, C; Chu, NQ; Colson, YL; Geller, AD; Grinstaff, MW; Hung, YP; Korunes-Miller, J; Mahvi, DA; Raut, CP; Sabatelle, R1
Li, P; Tian, Z; Wang, J; Wang, X; Yang, J; Yao, W; Zhang, F; Zhang, P1
Akazawa, T; Honma, K; Inoue, T; Kawachi, H; Kawamura, T; Kuhara, H; Kukita, Y; Kumagai, T; Kunimasa, K; Mizote, Y; Nakamura, H; Nishino, K; Tahara, H; Tamiya, M1
Blaydorn, L; Coats, J; Farley, JH; Khemka, V; Lynch, CA; McGahey, K; Niu, J; Sangal, A; Waypa, J; Weiss, GJ1
Alazraki, AL; Amankwah, EK; Cash, T; Clark, D; George, BA; Metts, JL; Olson, TA; Wasilewski-Masker, KJ1
Chawla, SP; Dry, SM; Eilber, FC; Hayashi, K; Higuchi, T; Hoffman, RM; Igarashi, K; Kawaguchi, K; Kimura, H; Li, Y; Miwa, S; Miyake, K; Nelson, SD; Oshiro, H; Razmjooei, S; Singh, SR; Tsuchiya, H; Wangsiricharoen, S; Yamamoto, N; Zhang, Z1
Chin, F; Farid, M; Ho, ZC; Jeevan, R; Lee, MJ; Ong, WS; Poon, D; Quek, R; Sairi, AN; Soh, LT; Teh, J; Teo, M1
Antoine, M; Bonnette, P; Cadranel, J; Cazes, A; Duruisseaux, M; Girard, N; Mazieres, J; Monnet, I; Ung, M; Vieira, T; Wislez, M1
Cao, J; Huang, XE; Liu, J; Lu, YY; Wu, XY1
Franciosi, AI; Guérios, SD; Pezzini, PC; Silva, DM1
Bao, Y; Chu, Q; Tan, S; Wu, T; Wu, Y; Zhang, Z; Zhuang, X1
Ajgal, Z; Alexandre, J; Boudou-Rouquette, P; Cessot, A; Chapuis, N; Emile, G; Fontenay, M; Goldwasser, F; Huillard, O; Tigaud, JM1
Akkar, OB; Karadayi, K; Karakus, S; Kurt, A; Ugurlu, GP; Yanik, A; Yildiz, C1
Ahn, KS; Jeong, SJ; Jung, MH; Kim, SH; Lee, EO; Lee, HJ; Lee, SY; Rhee, YH1
Ito, T; Kawashima, H; Nakatani, T; Omachi, T; Tamada, S1
Movva, S; Verschraegen, C1
Baranzelli, MC; Barnouin, L; Bay, JO; Bui, NB; Chevreau, C; Cupissol, D; Eymard, JC; Lortholary, A; Mita, M; Pivot, X; Savary, J; Thyss, A1
Bertino, JR; Li, W1
Alvarez, RD; Kim, RY; Omura, GA1
Arai, Y; Endo, M; Hagisawa, S; Hiramatu, M; Hoshi, S; Ohyama, C; Satoh, M; Watanabe, R1
Brodowicz, T; Grunt, T; Halaschek, J; Haller, G; Horak, P; Koestler, W; Krainer, M; Pribill, I; Tomek, S; Wiltschke, C; Zielinski, CC1
Aravantinos, G; Bafaloukos, D; Dimopoulos, AM; Fountzilas, G; Gogas, H; Kalofonos, C; Kosmidis, P; Linardou, H; Papadimitriou, C; Papakostas, P; Skarlos, D1
Katakami, N; Nakahira, A; Ogino, H; Sasaki, H1
Gabbert, HE; Grinstein, E; Haremza, J; Heikaus, S; Mahotka, C; Matuszek, KS; Ramp, U; Reinecke, P; Suschek, CV1
Aamdal, S; Catimel, G; Sternberg, C; Sulkes, A; van Hoesel, Q; Verweij, J; Wolff, I1
Asbury, RF; Boros, L; Chang, AY; Garrow, GC1
Catimel, G; Clavel, M; Kerbrat, P; Kerger, J; Tursz, T; van Glabbeke, M; van Hoesel, QG; van Oosterom, AT; van Pottelsberghe, C; Verweij, J1
Cheson, BD1
Goodin, S; Gosland, M; Hoffman, T; Tsuboi, C; Vore, M1
Aziz, SM; Crooks, PA; Gillespie, MN; Gosland, MP; Olson, JW; Tofiq, S; Tsuboi, CP1
Balcerzak, SP; Benedetti, J; Natale, RB; Weiss, GR1
Beketic-Oreskovic, L; Dumontet, C; Duran, GE; Sikic, BI; Steger, KA1
Asbury, RF; Boros, L; Chang, AY; Garrow, GC; Hui, L1
Verweij, J1
Ebbert, LP; Edmonson, JH; Gerstner, JB; Jung, SH; McGaw, H; Nascimento, AG1
Colvin, OM1
Valero, V1
Skubitz, KM1
Gian, VG; Johnson, TJ; Lynch, JW; Marsh, RW; Schuhmacher, C1
Chahinian, AP; Gluck, H; Holland, JF; Mandeli, JP; Naim, H; Teirstein, AS1
Bodin, F; Dumontet, C; Michal, Y1
Fox, S; Meyers, T; Rougraff, B; Sandler, A1
Bertino, JR; Casper, ES; Ilson, D; Leung, D; Pfister, D; Schwartz, GK; Sugarman, A; Waltzman, RJ; Woodruff, J1
Blaschke, TF; Duran, GE; Man, MC; Sikic, BI; Washington, CB1
Budman, DR; Calabro, A; Kreis, W1
Orel, NF1
Burger, RA; Chen, L; Cheng, H; Khan, SA; Lincoln, AJ; Mallarino, MC; Monk, BJ; Zaunbrecher, GM1
Bohling, CA; Forrest, LJ; Hershey, AE; Imondi, AR; Kurzman, ID; Placke, ME; Stonerook, M; Vail, DM1
Brodowicz, T; Köstler, WJ; Wiltschke, C; Zielinski, CC1
Gabbert, HE; Gerharz, CD; Knopf, C; Reinecke, P; Schmitz, M; Schneider, EM1
Baker, LH; Bruno, R; Hirth, J; Schott, A; Strawderman, M; Watkins, PB1
Buesa, J; Coleman, R; di Paola, ED; Judson, IR; Lee, SM; Ruka, W; Seynaeve, C; Tonelli, D; van Glabbeke, M; van Hoessel, R; Verweij, J1
Beketic-Oreskovic, L; Chen, GK; Durán, GE; Mangili, A; Sikic, BI1
Adams, LM; Budman, DR; Calabro, A; Kreis, W; Liu, XM; Stiel, L; Wang, LG1
Borzilleri, R; Fairchild, CR; Kim, SH; Kramer, RA; Lee, FY; Long, BH; Reventos-Suarez, C; Rose, WC; Vite, GD1
Fujikawa-Yamamoto, K; Ikeda, T; Murano, H; Ohdoi, C; Wang, S; Yamagishi, H1
Banerjee, D; Bertino, JR; Li, WW; Scotto, KW; Takahashi, N1
Amann, G; Attems, Y; Brodowicz, T; Fiebiger, WC; Hejna, M; Köstler, WJ; Krainer, M; Tomek, S; Wiltschke, CH; Zielinski, CC1
Brandl, M; Burger, AM; Fiebig, HH; Massing, U; Moog, R; Schubert, R; Schüler, J; Unger, C1
Banerji, N; Kanjilal, S; Kapur, V; Klausner, JS; Li, X1

Reviews

5 review(s) available for paclitaxel and Sarcoma, Epithelioid

ArticleYear
Systemic management strategies for metastatic soft tissue sarcoma.
    Drugs, 2011, Nov-12, Volume: 71, Issue:16

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Dioxoles; Doxorubicin; Gemcitabine; Humans; Ifosfamide; Lysine; Paclitaxel; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Tetrahydroisoquinolines; Trabectedin

2011
Advances in the treatment of gynecologic malignancies. Part 2: Cancers of the uterine corpus and ovary.
    Oncology (Williston Park, N.Y.), 2002, Volume: 16, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Female; Humans; Multicenter Studies as Topic; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Sarcoma; Uterine Neoplasms

2002
Active chemotherapy for bone metastasis in sarcomatoid renal cell carcinoma.
    International journal of clinical oncology, 2003, Volume: 8, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Carboplatin; Carcinoma, Renal Cell; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gemcitabine; Humans; Immunohistochemistry; Kidney Neoplasms; Neoplasm Staging; Nephrectomy; Paclitaxel; Sarcoma; Taxoids; Tomography, X-Ray Computed; Treatment Outcome

2003
Drug resistance in the treatment of sarcomas.
    Seminars in oncology, 1997, Volume: 24, Issue:5

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Paclitaxel; Platinum Compounds; Sarcoma

1997
[Taxotere in various solid tumors].
    Voprosy onkologii, 1998, Volume: 44, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Docetaxel; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Prostatic Neoplasms; Sarcoma; Skin Neoplasms; Soft Tissue Neoplasms; Taxoids; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms

1998

Trials

15 trial(s) available for paclitaxel and Sarcoma, Epithelioid

ArticleYear
A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus).
    British journal of cancer, 2017, Jun-27, Volume: 117, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Diarrhea; Docetaxel; Doxorubicin; Drug Eruptions; Fatigue; Female; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Polyethylene Glycols; Sarcoma; Small Cell Lung Carcinoma; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine; Vomiting

2017
Phase II trial of paclitaxel-epirubicin in patients with recurrent soft-tissue sarcoma.
    American journal of clinical oncology, 2002, Volume: 25, Issue:6

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Salvage Therapy; Sarcoma; Survival Analysis

2002
Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group.
    British journal of cancer, 2004, Nov-01, Volume: 91, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Doxorubicin; Female; Histiocytoma, Benign Fibrous; Humans; Leiomyosarcoma; Liposarcoma; Liposomes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Safety; Sarcoma; Survival Rate; Time Factors; Treatment Outcome

2004
Phase II studies of docetaxel in the treatment of various solid tumours. EORTC Early Clinical Trials Group and the EORTC Soft Tissue and Bone Sarcoma Group.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A Suppl 4

    Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Head and Neck Neoplasms; Humans; Melanoma; Middle Aged; Neoplasms; Paclitaxel; Sarcoma; Stomach Neoplasms; Taxoids

1995
Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide.
    Seminars in oncology, 1995, Volume: 22, Issue:3 Suppl 7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Adenoid Cystic; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Remission Induction; Sarcoma

1995
Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Europe; Female; Humans; Leukopenia; Male; Middle Aged; Nervous System Diseases; Paclitaxel; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Taxoids; Thrombocytopenia

1994
A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A Southwest Oncology Group study.
    Cancer, 1995, Dec-01, Volume: 76, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Prospective Studies; Remission Induction; Sarcoma; Thrombocytopenia

1995
Docetaxel: an interesting new drug for the treatment of head and neck cancers and soft tissue sarcomas.
    Anti-cancer drugs, 1995, Volume: 6 Suppl 4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Sarcoma; Taxoids

1995
Phase II study of docetaxel in advanced soft tissue sarcomas.
    American journal of clinical oncology, 1996, Volume: 19, Issue:6

    Topics: Adult; Aged; Alopecia; Anorexia; Antiemetics; Antineoplastic Agents, Phytogenic; Cause of Death; Dexamethasone; Diarrhea; Diphenhydramine; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leiomyosarcoma; Leukopenia; Male; Middle Aged; Nausea; Paclitaxel; Patient Selection; Premedication; Remission Induction; Sarcoma; Taxoids; Uterine Neoplasms; Vomiting

1996
Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
    Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:8 Suppl 8

    Topics: Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Cyclophosphamide; Dexamethasone; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Premedication; Remission Induction; Sarcoma; Taxoids

1997
Paclitaxel (Taxol) plus doxorubicin plus filgrastim in advanced sarcoma: a phase II study.
    American journal of clinical oncology, 1998, Volume: 21, Issue:3

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dose-Response Relationship, Drug; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Leiomyosarcoma; Male; Middle Aged; Paclitaxel; Recombinant Proteins; Sarcoma; Survival Rate

1998
Phase II trial of paclitaxel in patients with soft-tissue sarcoma.
    Cancer investigation, 1998, Volume: 16, Issue:7

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Nervous System Diseases; Neutropenia; Paclitaxel; Sarcoma

1998
The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:4

    Topics: Adult; Aged; Alanine Transaminase; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breath Tests; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Docetaxel; Erythromycin; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Mixed Function Oxygenases; Orosomucoid; Paclitaxel; Sarcoma; Soft Tissue Neoplasms; Taxoids

2000
Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: a study of the european organization for research and treatment of cancer soft tissue and b
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:10

    Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cross-Over Studies; Disease Progression; Docetaxel; Doxorubicin; Female; Humans; Male; Paclitaxel; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Taxoids; Treatment Outcome

2000
Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: results of a phase II trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:9

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Disease Progression; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Sarcoma; Soft Tissue Neoplasms; Taxoids; Treatment Outcome

2001

Other Studies

44 other study(ies) available for paclitaxel and Sarcoma, Epithelioid

ArticleYear
Synthesis and antitumor activity of novel paclitaxel-chlorambucil hybrids.
    Bioorganic & medicinal chemistry letters, 2001, Mar-26, Volume: 11, Issue:6

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Chlorambucil; Disease Models, Animal; Female; Humans; Inhibitory Concentration 50; Mice; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Sarcoma; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2001
A novel class of highly potent multidrug resistance reversal agents: disubstituted adamantyl derivatives.
    Bioorganic & medicinal chemistry letters, 2009, Sep-15, Volume: 19, Issue:18

    Topics: Adamantane; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cytochrome P-450 CYP3A; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Sarcoma; Structure-Activity Relationship

2009
Sustained Supratherapeutic Paclitaxel Delivery Enhances Irreversible Sarcoma Cell Death.
    Molecular cancer therapeutics, 2022, 11-03, Volume: 21, Issue:11

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Humans; Mice; Neoplasm Recurrence, Local; Paclitaxel; Sarcoma

2022
[Rare tumors: Angiosarcoma].
    Bulletin du cancer, 2023, Volume: 110, Issue:5

    Topics: Breast Neoplasms; Female; Hemangiosarcoma; Humans; Paclitaxel; Prognosis; Sarcoma

2023
High dose, dual-release polymeric films for extended surgical bed paclitaxel delivery.
    Journal of controlled release : official journal of the Controlled Release Society, 2023, Volume: 363

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Humans; Mice; Paclitaxel; Polymers; Sarcoma

2023
Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma.
    BMC cancer, 2020, Jul-28, Volume: 20, Issue:1

    Topics: Adult; Albumin-Bound Paclitaxel; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Progression-Free Survival; Retrospective Studies; Sarcoma; Treatment Outcome

2020
Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma.
    Immunotherapy, 2021, Volume: 13, Issue:10

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Immunological; Bevacizumab; Carboplatin; DNA Helicases; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nuclear Proteins; Paclitaxel; Sarcoma; Transcription Factors; Treatment Outcome

2021
Gemcitabine/nab-paclitaxel for pediatric relapsed/refractory sarcomas.
    Pediatric blood & cancer, 2018, Volume: 65, Issue:9

    Topics: Adolescent; Albumins; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Deoxycytidine; Disease-Free Survival; Female; Follow-Up Studies; Gemcitabine; Hematologic Diseases; Humans; Infections; Kaplan-Meier Estimate; Male; Paclitaxel; Recurrence; Salvage Therapy; Sarcoma; Young Adult

2018
The combination of gemcitabine and nab-paclitaxel as a novel effective treatment strategy for undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 111

    Topics: Albumins; Animals; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Models, Animal; Female; Gemcitabine; Humans; Mice; Mice, Nude; Middle Aged; Paclitaxel; Sarcoma; Treatment Outcome; Xenograft Model Antitumor Assays

2019
Cutaneous versus non-cutaneous angiosarcoma: clinicopathologic features and treatment outcomes in 60 patients at a single Asian cancer centre.
    Oncology, 2013, Volume: 85, Issue:3

    Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast; Female; Follow-Up Studies; Hemangiosarcoma; Humans; Male; Paclitaxel; Prognosis; Retrospective Studies; Sarcoma; Scalp; Singapore; Skin Neoplasms; Survival Analysis; Treatment Outcome

2013
Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013, Volume: 8, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Deoxycytidine; Docetaxel; Erlotinib Hydrochloride; Female; Follow-Up Studies; Gemcitabine; Giant Cell Tumors; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Pemetrexed; Prognosis; Quinazolines; Retrospective Studies; Sarcoma; Survival Rate; Taxoids; Vinblastine; Vinorelbine

2013
Comparison of efficacy and toxicity of first line chemotherapy with or without epirubicin for patients with advanced stage soft tissue sarcoma.
    Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Deoxycytidine; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Retrospective Studies; Sarcoma; Survival Rate; Young Adult

2013
Subcutaneous administration of paclitaxel in dogs with cancer: A preliminary study.
    The Canadian veterinary journal = La revue veterinaire canadienne, 2015, Volume: 56, Issue:8

    Topics: Animals; Carcinoma; Dog Diseases; Dogs; Female; Injections, Subcutaneous; Lymphoma; Male; Mastocytoma; Paclitaxel; Sarcoma

2015
D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
    International journal of nanomedicine, 2015, Volume: 10

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Lung Neoplasms; MCF-7 Cells; Mice; Micelles; Nanoparticles; Ovarian Neoplasms; Paclitaxel; Particle Size; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Sarcoma; Succinates; Vitamin E

2015
Risk factors for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia over time: assessment of monocyte count and baseline clinical parameters.
    Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:5

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Case-Control Studies; Doxorubicin; Female; Hand-Foot Syndrome; Hematologic Diseases; Humans; Leukocyte Count; Male; Middle Aged; Monocytes; Ovarian Neoplasms; Paclitaxel; Pilot Projects; Polyethylene Glycols; Retrospective Studies; Sarcoma; Stomatitis; Thymus Neoplasms; Young Adult

2015
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for gynecological malignancies: a single center experience.
    European journal of gynaecological oncology, 2016, Volume: 37, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cohort Studies; Cytoreduction Surgical Procedures; Endometrial Neoplasms; Fallopian Tube Neoplasms; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Retrospective Studies; Sarcoma; Survival Rate; Treatment Outcome; Uterine Neoplasms; Young Adult

2016
Hydrocinchonine, cinchonine, and quinidine potentiate paclitaxel-induced cytotoxicity and apoptosis via multidrug resistance reversal in MES-SA/DX5 uterine sarcoma cells.
    Environmental toxicology, 2011, Volume: 26, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cinchona Alkaloids; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Paclitaxel; Quinidine; Sarcoma; Uterine Neoplasms

2011
[Primary urothelial carcinoma with sarcomatous transformation of the prostate].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2010, Volume: 101, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Cystectomy; Deoxycytidine; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Prostatectomy; Prostatic Neoplasms; Radiotherapy, Adjuvant; Sarcoma; Treatment Outcome; Urethral Neoplasms

2010
Fas-mediated signaling enhances sensitivity of human soft tissue sarcoma cells to anticancer drugs by activation of p38 kinase.
    Molecular cancer therapeutics, 2002, Volume: 1, Issue:14

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Caspase 9; Caspases; Cell Cycle; Cell Death; Cell Separation; Chalcone; Chalcones; Cytochrome c Group; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Activation; fas Receptor; Flow Cytometry; Humans; Imidazoles; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Pyridines; Sarcoma; Signal Transduction; Soft Tissue Neoplasms; Time Factors; Tumor Cells, Cultured

2002
Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines.
    European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; DNA Fragmentation; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Flow Cytometry; Humans; Immunohistochemistry; Membrane Glycoproteins; Paclitaxel; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sarcoma; Soft Tissue Neoplasms; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53

2003
Long-term survival of a pulmonary artery sarcoma produced by aggressive surgical resection and adjuvant chemoradiotherapy.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2007, Volume: 32, Issue:2

    Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Chemotherapy, Adjuvant; Humans; Male; Paclitaxel; Pulmonary Artery; Radiotherapy, Adjuvant; Sarcoma; Treatment Outcome; Vascular Neoplasms

2007
Paclitaxel (Taxol)-induced apoptosis in human epithelioid sarcoma cell lines is enhanced by upregulation of CD95 ligand (FasL/Apo-1L).
    Journal of cancer research and clinical oncology, 2008, Volume: 134, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Fas Ligand Protein; fas Receptor; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Paclitaxel; RNA, Messenger; Sarcoma; Signal Transduction; Up-Regulation

2008
Clinical trials referral resource. Update on taxol trials.
    Oncology (Williston Park, N.Y.), 1993, Volume: 7, Issue:1

    Topics: Acute Disease; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Leukemia, Myeloid; Lung Neoplasms; Ovarian Neoplasms; Paclitaxel; Sarcoma

1993
17 beta-estradiol glucuronide: an inducer of cholestasis and a physiological substrate for the multidrug resistance transporter.
    Cancer research, 1993, Nov-15, Volume: 53, Issue:22

    Topics: Cholestasis; Doxorubicin; Drug Resistance; Estradiol; Estriol; Etoposide; Humans; Leukemia, Myeloid; Paclitaxel; Sarcoma; Tumor Cells, Cultured; Vinblastine

1993
Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine.
    Cancer chemotherapy and pharmacology, 1996, Volume: 37, Issue:6

    Topics: Antineoplastic Agents; Doxorubicin; Drug Resistance, Multiple; Etoposide; Guanidines; Humans; Paclitaxel; Polymers; Sarcoma; Spermine; Tumor Cells, Cultured; Vinblastine

1996
Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol).
    Cancer research, 1996, Mar-01, Volume: 56, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Drug Resistance; Female; Humans; Molecular Sequence Data; Mutation; Paclitaxel; Sarcoma; Tubulin; Tumor Cells, Cultured; Uterine Neoplasms

1996
Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Seminars in oncology, 1996, Volume: 23, Issue:3 Suppl 6

    Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukopenia; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Pilot Projects; Remission Induction; Sarcoma; Thrombocytopenia

1996
A phase I study of ambulatory continuous infusion paclitaxel.
    Anti-cancer drugs, 1997, Volume: 8, Issue:9

    Topics: Adult; Aged; Ambulatory Care; Antineoplastic Agents, Phytogenic; Clinical Trials, Phase I as Topic; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Sarcoma; Soft Tissue Neoplasms

1997
A phase II trial of paclitaxel in the treatment of recurrent or metastatic soft tissue sarcomas or bone sarcomas.
    Journal of experimental therapeutics & oncology, 1996, Volume: 1, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Clinical Trials, Phase II as Topic; Female; Humans; Male; Middle Aged; Paclitaxel; Recurrence; Sarcoma; Soft Tissue Neoplasms

1996
Effectiveness of cisplatin, paclitaxel, and suramin against human malignant mesothelioma xenografts in athymic nude mice.
    Journal of surgical oncology, 1998, Volume: 67, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Fibrosarcoma; Humans; Mesothelioma; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Pleural Neoplasms; Sarcoma; Suramin; Transplantation, Heterologous; Tumor Cells, Cultured

1998
Potential interactions between antitubulin agents and temperature: implications for modulation of multidrug resistance.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Biological Transport; Cell Division; Cell Survival; Docetaxel; Drug Resistance, Multiple; Humans; Hyperthermia, Induced; Leukemia, Erythroblastic, Acute; Paclitaxel; Sarcoma; Taxoids; Temperature; Tumor Cells, Cultured; Vinblastine

1998
Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Nov-01, Volume: 19, Issue:3

    Topics: Anti-HIV Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; HIV Protease Inhibitors; Humans; Indinavir; Leukemia, Erythroblastic, Acute; Nelfinavir; Paclitaxel; Ritonavir; Saquinavir; Sarcoma; Tumor Cells, Cultured; Uterine Neoplasms; Vinblastine

1998
In vitro evaluation of synergism or antagonism with combinations of new cytotoxic agents.
    Anti-cancer drugs, 1998, Volume: 9, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Gemcitabine; Humans; Male; Paclitaxel; Prostatic Neoplasms; Sarcoma; Tumor Cells, Cultured; Vinblastine; Vinorelbine

1998
Protein kinase C isoform expression and activity alter paclitaxel resistance in vitro.
    Gynecologic oncology, 1999, Volume: 72, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; In Vitro Techniques; Isoenzymes; Paclitaxel; Protein Kinase C; Sarcoma; Signal Transduction; Tumor Cells, Cultured; Uterine Neoplasms

1999
Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:9

    Topics: Administration, Inhalation; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Dog Diseases; Dogs; Doxorubicin; Female; Lung Neoplasms; Male; Melanoma; Paclitaxel; Sarcoma

1999
Efficacy of docetaxel in the second-line treatment of locally advanced or metastatic soft tissue sarcoma after failure of chemotherapy with anthracycline or ifosfamide.
    American journal of clinical oncology, 1999, Volume: 22, Issue:5

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Male; Paclitaxel; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Taxoids

1999
Growth inhibitory effects of paclitaxel on human epithelioid sarcoma in vitro: heterogeneity of response and the multidrug resistance phenotype.
    Cancer, 2000, Apr-01, Volume: 88, Issue:7

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cell Differentiation; Cell Division; Drug Resistance, Multiple; Flow Cytometry; Humans; Micronuclei, Chromosome-Defective; Microscopy, Electron; Microtubules; Multidrug Resistance-Associated Proteins; Paclitaxel; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma; Time Factors; Tumor Cells, Cultured

2000
MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells.
    British journal of cancer, 2000, Volume: 83, Issue:7

    Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclosporins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Multidrug Resistance-Associated Proteins; Mutation; Neoplasm Proteins; Paclitaxel; Phenotype; Rhodamine 123; RNA, Messenger; Sarcoma; Tritium; Tumor Cells, Cultured; Uterine Neoplasms; Vault Ribonucleoprotein Particles; Vinblastine

2000
Synergism of cytotoxic effects of vinorelbine and paclitaxel in vitro.
    Cancer investigation, 2000, Volume: 18, Issue:8

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Female; Humans; Male; Paclitaxel; Prostatic Neoplasms; Sarcoma; Tumor Cells, Cultured; Vinblastine; Vinorelbine

2000
BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:5

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Survival; Colonic Neoplasms; Disease Models, Animal; Drug Resistance, Neoplasm; Epothilones; Epoxy Compounds; Female; Humans; Infusions, Parenteral; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Sarcoma; Thiazoles; Tubulin; Tumor Cells, Cultured; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays

2001
Establishment of a tetraploid Meth-A cell line through polyploidization by demecolcine but not by staurosporine, K-252A and paclitaxel.
    Cell proliferation, 2001, Volume: 34, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carbazoles; Cell Count; Cell Cycle; Cell Division; Demecolcine; DNA; Enzyme Inhibitors; Flow Cytometry; Indole Alkaloids; Karyotyping; Mice; Paclitaxel; Ploidies; Sarcoma; Staurosporine; Tumor Cells, Cultured

2001
Sequence-dependent enhancement of cytotoxicity produced by ecteinascidin 743 (ET-743) with doxorubicin or paclitaxel in soft tissue sarcoma cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; Cell Division; Dioxoles; Doxorubicin; Drug Synergism; Flow Cytometry; Humans; Inhibitory Concentration 50; Isoquinolines; Microscopy, Fluorescence; Paclitaxel; Sarcoma; Tetrahydroisoquinolines; Trabectedin; Trimetrexate; Tumor Cells, Cultured

2001
Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels.
    Cancer chemotherapy and pharmacology, 2002, Volume: 49, Issue:5

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Deoxycytidine; Docetaxel; Gels; Gemcitabine; Half-Life; Humans; Liposomes; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Phospholipids; Sarcoma; Taxoids; Tissue Distribution; Transplantation, Heterologous; Urinary Bladder Neoplasms; Vindesine

2002
Evaluation of in vitro chemosensitivity of vaccine-associated feline sarcoma cell lines to vincristine and paclitaxel.
    American journal of veterinary research, 2002, Volume: 63, Issue:5

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cat Diseases; Cats; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Inhibitory Concentration 50; Male; Paclitaxel; Sarcoma; Tumor Cells, Cultured; Vaccination; Vincristine

2002